Navigation Links
MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009
Date:12/3/2009

WARRENDALE, Pa., Dec. 3 /PRNewswire/ -- Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Connect.PACS(TM) product, enabling the first radiology informatics capabilities of its kind, is the latest release in the company's newly branded Certegra(TM) Informatics Platform.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091203/NE20631 )

Certegra products automate and advance how patient and study information is generated, integrated and mobilized within radiology. Certegra products automate record keeping; integrate injection records into PACS; personalize contrast dosing (P3T(TM)); integrate CT scanner and injector operation (ISI); and enable remote equipment service.

"MEDRAD is using informatics to open up access to data providing clinical, research, and operational benefits within an enterprise," says William Boonn, M.D., Chief 3D and Advanced Imaging, Hospital of the University of Pennsylvania. "Clinical records integration offers built-in workflow efficiencies and productivity potential. Without it, radiologists have to either track down the technologist who performed a study or go to the scanner directly to get the information they need."

Certegra's Connect.PACS builds on current platform capabilities including information capture, automated record keeping and compliance documentation, as well as additional reporting options. Connect.PACS immediately transfers a patient's CT contrast-injection record to PACS, eliminating the need to manually enter injection information. The injection record transfer enables radiologists to view injection protocols alongside the patient's PACS image set for real-time and retrospective image analysis.

*Picture Archiving and Communication System

"Demand to deliver improved clinical outcomes while realizing greater cost efficiencies and workflow productivity has never been greater for healthcare providers," says Anthony Cinalli, executive director, MEDRAD Radiology. "We're harnessing the power of informatics to help healthcare professionals meet these needs in ways that, until now, have been largely untapped."

About MEDRAD, Inc.

MEDRAD, Inc. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a business of Bayer Medical Care. More company information is available at www.medrad.com.

Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Forward-looking statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.


For additional information contact:
Luanne Radermacher, MEDRAD
724-940-7968
lradermacher@medrad.com

SOURCE MEDRAD, Inc.


'/>"/>
SOURCE MEDRAD, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
11. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... The leader in accelerated orthodontics, OrthoAccel ® Technologies, ... of the 2015 Townie Choice Award in the accelerated ... that speeds up orthodontic tooth movement by as much ... treatment, AcceleDent was selected by orthodontists from across the ... survey of the most reliable and reputable products in ...
(Date:2/9/2016)... N.J. , Feb. 9, 2016  Johnson & ... RBC Capital Markets Global Healthcare Conference on Tuesday, Feb. ... City.  Dominic Caruso , Vice President, Finance & ... Chairman, Consumer will represent the Company in a session ... www.investor.jnj.com . --> www.investor.jnj.com . --> ...
(Date:2/9/2016)... BETHESDA, Md. , Feb. 9, 2016 /PRNewswire-USNewswire/ ... community for pharmaceutical professionals developing and manufacturing sterile ... Global Sterile Manufacturing Regulatory Guidance Comparison – With ... regulatory guidance documents issued by the U.S. FDA, ... World Health Organization. --> ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... February 09, 2016 , ... ZipHearing.com is proud ... affordable hearing aids , increase industry transparency, and promote awareness of hearing ... , “For the average consumer, the hearing aid industry is esoteric and difficult ...
(Date:2/9/2016)... ... 09, 2016 , ... IsoComforter, Inc., one of the Nation’s ... designed, innovative shoulder wrap. The newly designed shoulder wrap has been specifically ... and shoulder to promote faster healing. It is highly recommended for arm or ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... “Ebola: In Praise of Prevention,” an animated video designed to prevent ... French translations of the video are being distributed throughout Togo, Liberia, Sierra Leone, ...
(Date:2/9/2016)... ... 09, 2016 , ... i2i Systems, an early innovator and developer of population ... the latest KLAS report, Population Health Management 2015: How Far Can Your Vendor Take ... health management (PHM). The latest KLAS Report, leveraging over 200 user interviews, shines ...
(Date:2/9/2016)... VA (PRWEB) , ... February 09, 2016 , ... ... Small Mammal Prize has officially been won. A team from 21st Century Medicine ... discovered a way to preserve the delicate neural circuits of an intact rabbit ...
Breaking Medicine News(10 mins):